Keros Therapeutics, Inc.
Institutional Ownership & Holdings Analysis
About
keros-therapeutics is a publicly traded company tracked by institutional investors. This page displays information about the institutional ownership of the company's shares, showing which investment funds and asset managers hold positions in the company.
Top Institutional Holders
| # | Institution | Value |
|---|---|---|
| 1 | Nuveen, LLC(2025-03-31) | $94.5M |
| 2 | BRAIDWELL LP(2024-12-31) | $30.0M |
| 3 | BlackRock, Inc.(2025-03-31) | $28.4M |
| 4 | Darwin Global Management, Ltd.(2024-12-31) | $26.7M |
| 5 | JPMORGAN CHASE & CO(2025-03-31) | $26.5M |
| 6 | VANGUARD GROUP INC(2025-03-31) | $26.2M |
| 7 | Logos Global Management LP(2025-03-31) | $20.4M |
| 8 | Holocene Advisors, LP(2024-12-31) | $19.0M |
| 9 | MORGAN STANLEY(2025-03-31) | $16.9M |
| 10 | ADAR1 Capital Management, LLC(2025-03-31) | $15.1M |
| 11 | Jefferies Financial Group Inc.(2024-12-31) | $13.7M |
| 12 | STATE STREET CORP(2025-03-31) | $13.3M |
| 13 | D. E. Shaw & Co., Inc.(2025-03-31) | $12.9M |
| 14 | FEDERATED HERMES, INC.(2025-03-31) | $12.5M |
| 15 | MANGROVE PARTNERS IM, LLC(2024-12-31) | $11.7M |
| 16 | TANG CAPITAL MANAGEMENT LLC(2025-03-31) | $11.2M |
| 17 | ORBIMED ADVISORS LLC(2025-03-31) | $10.4M |
| 18 | ALKEON CAPITAL MANAGEMENT LLC(2025-03-31) | $8.7M |
| 19 | Lynx1 Capital Management LP(2024-12-31) | $8.6M |
| 20 | GEODE CAPITAL MANAGEMENT, LLC(2025-03-31) | $8.2M |
As of 2025-03-31
Value:$94.5M
As of 2024-12-31
Value:$30.0M
As of 2025-03-31
Value:$28.4M
As of 2024-12-31
Value:$26.7M
As of 2025-03-31
Value:$26.5M
As of 2025-03-31
Value:$26.2M
As of 2025-03-31
Value:$20.4M
As of 2024-12-31
Value:$19.0M
As of 2025-03-31
Value:$16.9M
As of 2025-03-31
Value:$15.1M
As of 2024-12-31
Value:$13.7M
As of 2025-03-31
Value:$13.3M
As of 2025-03-31
Value:$12.9M
As of 2025-03-31
Value:$12.5M
As of 2024-12-31
Value:$11.7M
As of 2025-03-31
Value:$11.2M
As of 2025-03-31
Value:$10.4M
As of 2025-03-31
Value:$8.7M
As of 2024-12-31
Value:$8.6M
As of 2025-03-31
Value:$8.2M
Total Institutional Holders:213
Top 10 Holders Own:52.2%